Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wentong Huoxue cream for diabetic peripheral neuropathy
ChiCTR2300078843Phase 3Not yet recruiting
- Sponsor
- Traditional Chinese Medicine Hospital Affiliated to Xinjiang Medical University
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Wentong Huoxue cream in diabetic polyneuropathy (DPN) (2 arms), sponsored by Traditional Chinese Medicine Hospital Affiliated to Xinjiang Medical University. Primary endpoints: Toronto Clinical Scoring System and Visual Analog Scale pain score. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
Wentong Huoxue cream
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on ChiCTR2300078843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078843.